MEDICAL REGISTRY

Long-acting growth hormone (LAGH) therapy is changing the game for people with growth hormone deficiency (GHD). It's a big step forward because it means fewer injections and better treatment adherence. In Germany, three LAGH products have hit the market: lonapegsomatropin, somapacitan, and somatrog

A rare genetic condition is shedding light on an unexpected connection to ovarian cancer. This condition, known as activated PI3-kinase-delta syndrome, or APDS, is an inherited immune system disorder. It affects how the body's defense system works, making individuals more susceptible to various type